CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Transderm Laboratories Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Transderm Laboratories Corporation
101 Sinking Springs Lane,
Phone: (717) 764-1191p:717 764-1191 Emigsville, PA  17318  United States Ticker: TLCC TLCC

This company is no longer actively traded on any major stock exchange.

Business Summary
Transderm Laboratories Corporation (Transderm) is engaged in the development, manufacture and marketing of transdermal drug delivery systems. Transderm operates principally through its 98.5% owned subsidiary, Hercon Laboratories Corporation (Hercon). The Company is 90% owned by Health-Chem Corporation. As of June 30, 2007, the Company’s primary product was transdermal nitroglycerin patches (the Hercon products) used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris.
(Source: 10QSB)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/200712/31/2006YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Andy E.Yurowitz 71 2/1/2000 2/1/2000
Chief Financial Officer, Treasurer, Secretary Ronald J.Burghauser 46 11/1/2003 11/1/2003
Director Andrew J.Levinson 58 1/1/2000 1/1/2000
Director ManfredMayerfeld 75 1/1/2000 1/1/2000

Business Names
Business Name
Hercon Laboratories Corporation
TLCC
Transderm Laboratories Corporation

General Information
Number of Employees: 55 (As of 12/31/2006)
Outstanding Shares: 40,000,000 (As of 6/2/2008)
Shareholders: 142
Stock Exchange: OTC
Federal Tax Id: 133518345


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023